|
Cyclacel Pharmaceuticals
|
20/12
|
0,3299
|
-0,33%
|
0,339
|
0,3251 - 0,35
|
|
Cyclerion Therapeutics,Inc
|
20/12
|
3,19
|
+8,14%
|
3,03
|
2,8345 - 3,43
|
|
Cyclo Therapeutics
|
20/12
|
0,615
|
-0,81%
|
0,632
|
0,6 - 0,632
|
|
Cyclo Therapeutics Inc Warrant 2020-14.11.25 On Cyclo
|
20/12
|
0,1249
|
-2,42%
|
0,1024
|
0,08 - 0,1249
|
|
Cyngn
|
20/12
|
0,4689
|
-70,88%
|
0,37
|
0,3514 - 0,489
|
|
Cyrnq
|
21/05
|
0,0001
|
0,00%
|
0,0001
|
0,0001 - 0,0001
|
|
Cytek Biosciences
|
20/12
|
6,32
|
+2,10%
|
6,04
|
6,04 - 6,39
|
|
Cytof
|
---
|
0
|
0,00%
|
0
|
---
|
|
Cytokinetics, Incorporated
|
20/12
|
48,91
|
+4,64%
|
46,85
|
46,85 - 50,32
|
|
Cytomed Therapeutics
|
20/12
|
2,56
|
+4,92%
|
2,543
|
2,25 - 2,65
|
|
Cytomx Therapeutics
|
20/12
|
1,08
|
-1,82%
|
1,06
|
1,03 - 1,1
|
|
Cytosorbents
|
20/12
|
0,9149
|
+3,98%
|
0,858
|
0,858 - 0,92
|